About Author : Akshay Kedari


Akshay Kedari

Akshay holds a Bachelor’s degree in computer engineering. Despite having a penchant for software development and the like, Akshay took to writing as a career owing to his passion for the field. Presently, Akshay writes articles for itresearchbrief.com and a few other portals. He has also worked awhile in web development, and expertly harnesses his knowledge of the degree to his professional advantage in content development.



Contribution by: Akshay Kedari

DSV buys Panalpina to become one of the largest airfreight providers

Denmark company takes over Swiss logistics group Panalpina in a deal of over USD 5.5 million.   This acquisition will create the world’s fourth largest airfreight company.   Denmark based DSV A/S recently announced the completio...


Read More >>
Russian nuclear power station shuts off following safety system error

Urals facility shuts down Byeloyarsk power unit at 9.15 local time after automated safety system’s false activation.   This incident adds to the rising concerns regarding Russia’s nuclear activities. According to the Rosatom St...


Read More >>
Coinmine raises $2.5 million in investment in its seed funding round

Republic Labs, M13 Ventures, Gumi Crypto & early Uber financer Shervin Pishevar contributed to this funding.   Almost 10% of customers purchase from Coinmine again and less than 4% Coinmine one devices are returned. Coinmine, the make...


Read More >>
SoftBank to trade a stake in Bharti Airtels telecom business

The Japanese firm, SoftBank has been reported to purchase a stake in the Airtel business of India either directly or indirectly through a holding company. Bharti Enterprises and SoftBank have established a 50:50 joint venture already since 2011. ...


Read More >>
FDA warns four companies to recall 44 tobacco products from the market

The agency has already directed number of firms operating in the tobacco area to remove some of their products from the market. The U.S. Food and Drug Administration (FDA) has recently released warning letters against four companies to recall 4...


Read More >>
Oncternal commences phase 2 trial of cirmtuzumab-ibrutinib combination

Under the phase 2 trial approximately 90 patients with CLL will receive either ibrutinib or ibrutinib coupled with cirmtuzumab Oncternal Therapeutics, a biotechnology company, has reportedly announced opening of enrollment for patients suffering fro...


Read More >>
SELLAS completes enrollment of women for Phase 2 VADIS clinical trial

This test would give opportunity to understand if NPS can induce immune response in patients with DCIS. The VADIS outputs could tell the company about potential synergies among standard therapies and NPS in the women suffering from DCIS. SELLAS ...


Read More >>
Roche’s drug with chemo reduces disease worsening due to bladder cancer

· Outputs would be shared globally with healthcare authorities at the next medical meeting. · While encouraging survival results were observed, the data isn’t mature enough and a follow-up would continue up until next planned ana...


Read More >>
Texas joins other states in lawsuit to halt T-Mobile-Sprint deal

The state is suing T-Mobile’s $26.5 billion takeover of rival cellphone company Sprint. Texas has recently joined nearly a dozen American states that is filing a motion to stop T-Mobile’s acquisition of rival telecommunication ...


Read More >>
TP Therapeutics’ CEO to present the 39th Annual Growth Conference

CEO Dr. Athena Countouriotis will participate in a question and answer session at the conference in Boston this month. Turning Point Therapeutics, Inc., a clinical-stage oncology company focused on developing novel drugs to address treatment re...


Read More >>
Novartis announces result from Phase 3 PARAGON-HF trial in HFpEF

Novartis International AG, a Swiss-based pharmaceutical company recently announced results from Phase 3 PARAGON-HF trial in HFpEF (heart failure patients with preserved ejection fraction), investigating the efficacy & safety of sacubitril/ valsar...


Read More >>
Zuckerberg thrilled about WhatsApp Payments beta testing in India

With 400 million users, India is the biggest market for WhatsApp. Facebook Inc. now awaits regulatory approval for a complete roll-out of WhatsApp Pay in India. Mark Zuckerberg, Chief Executive of Facebook stated that beta testing of WhatsApp Pa...


Read More >>
Coca-Cola to officially bring its alcoholic beverage to Japan

Coca-Cola is set to debut in the alcohol market with lemon chuhai in Japan in October this year.   This is marked to be the company’s first ever hard drink. The global beverage giant, Coca-Cola has come up with its first ever alcohol...


Read More >>
KAZIA to test GDC-0084 with radiotherapy at MSK Cancer Center

The clinical study is expected to enroll about 18-30 cancer patients for testing. The clinical trial is expected to take approximately two years to complete. KAZIA Therapeutics Ltd., (Kazia), a renowned oncology-focused biotechnology firm based ...


Read More >>
Orphazyme finishes enrollment in phase 3 study assessing arizoclomol

The phase 3 study of arimoclomol for ALS is a 76-week, placebo-controlled, randomized study being conducted at 30 centers of excellence in Europe and North America. The biopharmaceutical company Orphazyme A/S has reportedly announced that it has fin...


Read More >>
Cipla announces reentry into Chinese market with Jiangsu Acebright

The global pharmaceutical giant Cipla reportedly announced that it has reentered Chinese market in an alliance with Jiangsu Acebright. The company will set up a manufacturing plant for respiratory products in China under the joint venture. According...


Read More >>
PayPal extends its international money transfer service to Europe

Transfer of money to international markets would become easier through the service.   The money transfer service would be made available across 32 European markets. PayPal Holdings, Inc. (PayPal), an American multinational online payments ...


Read More >>
Microsoft’s $399 Azure Kinect Developer Kit to ship in China & the US

Microsoft, the tech giant, recently announced that its Azure Kinect Developer Kit, a $399 perception system for speech solutions & computer vision, will be available for shipping to pre-order customers in the U.S. and China, report sources. Repo...


Read More >>
Pulmatrix to begin Phase-2 clinical trials, activates 3 sites in the U.S.

Pulmatrix, Inc. has reportedly activated three sites in the United States for the phase-2 clinical trial of Pulmazole (PUR1900). It is an inhaled formulation consisting of itraconazole for treating allergic bronchopulmonary aspergillosis (ABPA) in pa...


Read More >>
Dermata Therapeutics declares positive outcomes from DMT410 trial

In a recent turn of events, Dermata Therapeutics, a development-stage biotechnology company, has announced positive outcomes from Phase I proof of concept clinical trial of DMT410 (which is a combination of DMT310 and botulinum toxin), for treating p...


Read More >>
ZipLine acquires Florida-based gift card payment platform SmartClixx

The acquisition would facilitate ZipLine an entry into the gift card segment. The newly acquired assets further complement ZipLine’s existing customer payments as well as loyalty capabilities. ZipLine, a renowned rewards and mobile payment...


Read More >>
DoT to launch a tech solution for tracking lost mobile phones

The tracking system would detect stolen mobile phones, even if the IMEI number is changed or the SIM card is removed. DoT (The Department of Telecommunications) recently announced the launch of a technology solution to enable detection of stolen or ...


Read More >>
Microsoft to withdraw SQL Server and Window Server 2008 services

Ingram Micro offers Cloud migration solutions for businesses impacted by Microsoft’s move. Microsoft Corporation, the technology company recently announced to suspend its SQL Server in 2019 and Windows Server 2008 by January 2020. Microsoft ha...


Read More >>
BP ventures backs Calysta with $30M for food security enhancement

Calysta, a biotechnology company recently announced that venture capital firm, BP Ventures invested $30 million to support rollout of Calysta’s FeedKind® protein, which is expected to improve global food security, cite sources. F...


Read More >>
Wysa raises $2M in pre-series A funding round led by pi Ventures

Wysa has helped over 1.2M people across 30 countries through 80 million conversations. Wysa, an AI mental health startup based in Bengaluru, has reportedly raised $2 million (INR 15 Cr) in a pre-series A funding round led by pi Ventures. As per trus...


Read More >>
Thrive Global & P&G tie up on consumer behavior change via Microsteps

The New York-based Thrive Global, has reportedly signed a partnership with P&G, the American multinational consumer goods corporation to combine behavioral science and daily habits pertaining to P&G’s products to help consumers improve ...


Read More >>
Huawei presses Verizon to pay $1 billion as patent licensing charges

Amid clash with the U.S. government, the Chinese company says US-based Verizon is liable to pay fees for more than 230 of its patents. Huawei, the Chinese telecommunications equipment company recently demanded $1 billion patent licensing fees from a...


Read More >>
Uber faces fresh competition as rival Bolt enters London market

Estonia-based transportation network company Bolt, formerly known as Taxify, recently launched in London, the biggest ride-hailing market in Europe. The company joins an expanding list of start-ups in an attempt to gain market share from Uber in Lond...


Read More >>
Kite unveils study results for KTE-X19 in acute lymphoblastic leukemia

The outcome of the Phase 1 ZUMA-3 study was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.   The results would be facilitating guidance on KTE-X19 safety & dosing management to help the ongoing Phase 2...


Read More >>
Reata announces patient enrollment in clinal trial of Bardoxolone Methyl

Reata Pharmaceuticals, a clinical-stage biopharmaceutical company recently announced enrollment of first patient in the Phase 3 FALCON trial of bardoxolone in patients with ADPKD (autosomal dominant polycystic kidney disease), cites source. For the ...


Read More >>
Alembic Pharma gets FDA approval for Solifenacin Succinate tablets

The FDA approval was awarded to Solifenacin Succinate tablets’ abbreviated new drug application (ANDA). The pharmaceutical firm now holds a total of 94 ANDA approvals from the US health regulator. Alembic Pharmaceuticals Ltd., (Alembic Pha...


Read More >>
Noxopharm publishes results from LuPIN trial involving Veyonda

177Lu-PSMA-617 is an experimental radiopharmaceutical which comprises of a peptide. The clinical-stage drug development company Noxopharm has reportedly announced positive provisional results from the LuPIN study concerning the Veyonda drug created ...


Read More >>
Nuro and Kroger unveil autonomous delivery service in Houston

The novel service would be made available via two stores of Kroger in Houston and will serve consumers residing in four local zip codes Nuro, the robotics firm transforming local commerce, and Kroger, the largest American grocery retailer, have join...


Read More >>
Qatar Petroleum on the verge of acquiring an interest in block A5A

The acquisition is speculated to strengthen Qatar Petroleum’s international oil & gas portfolio. Qatar’s state owned petroleum company Qatar Petroleum has reportedly inked an agreement deal with Eni. The deal entails the petroleum fi...


Read More >>
GTx Inc. announces merger with San Diego-based Oncternal Therapeutics

The companies are planning for a reverse merger which would end the Memphis operations of GTx   The merger will create a publicly traded, clinical-stage firm to develop novel cancer treatments GTx Inc., a Tennessee based pharmaceutical fir...


Read More >>
Cisco pours in CAD 15 million to expand footprint in Western Canada

The funding will be used to mainly augment job generation and skills development across Western Canada. Multinational technology conglomerate Cisco has reportedly announced that it plans to invest CAD 15 million in Western Canada’s secure digi...


Read More >>
Grab seeks more investment after record $4.5B funding round in SE Asia

Grab will look to partner with more companies that can provide complementary technology and services to help grow its business in the region Grab, the ride-hailing company headquartered in Singapore, is reportedly planning to raise more funding from...


Read More >>